Skip to main content
HWAIL PHARM. CO., LTD logo

HWAIL PHARM. CO., LTD — Investor Relations & Filings

Ticker · 061250 ISIN · KR7061250007 KO Manufacturing
Open in API
Filings indexed 274 across all filing types
Latest filing 2023-05-12 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 061250

About HWAIL PHARM. CO., LTD

http://www.hwail.com/

Hwail Pharm. Co., Ltd. is a pharmaceutical company that specializes in the research, development, manufacturing, and distribution of Active Pharmaceutical Ingredients (APIs). The company also provides a range of finished drug formulations, including generic and patented medications, as well as functional health products. A core focus of the organization is maintaining high standards through continuous R&D investment and rigorous quality control processes to develop and produce its pharmaceutical products.

Recent filings

Filing Released Lang Actions
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for HWAIL PHARMACEUTICAL CO., LTD. covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial data, business operations, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-12 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details a change in shareholding (specifically, the acquisition of collateral rights) by Korea Securities Finance Corp in Hwail Pharmaceutical. This type of filing is a mandatory disclosure for major shareholders crossing specific ownership thresholds and is classified as a Major Shareholding Notification.
2023-04-10 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Annual General Meeting (AGM) for the company '화일약품' (Hwail Pharmaceutical). It details the approval of financial statements, director appointments, and voting outcomes for various agenda items. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2023-03-24 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's representative director (CEO). It details the resignation of the former CEO and the appointment of a new one, including the effective date, board resolution date, and the new CEO's background. This falls directly under the definition of Board/Management Information (MANG).
2023-03-24 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 42nd fiscal year (2022) of Hwail Pharmaceutical Co., Ltd. It contains detailed financial data, management discussions, business operations, and corporate governance information. This is the standard Korean regulatory filing equivalent to an Annual Report (10-K). FY 2022
2023-03-16 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from Hwa-il Pharm. It provides the audit opinion (unqualified/appropriate), key financial data (assets, liabilities, revenue, profit/loss), and details regarding the external auditor (Samduk Accounting Corp). While it contains financial data, it is a summary disclosure of the audit results rather than the full annual report (10-K) or a standalone audit report document. According to the 'Menu vs Meal' rule, this is a regulatory announcement of the audit report's availability and key findings, which fits the 'Audit Report / Information' (AR) category as it specifically details the audit opinion and financial summary. FY 2022
2023-03-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.